Vesalius Longevity Labs Inc. recorded three buy transactions on November 19, 2026, all executed by Director and Senior Officer James McRoberts. These acquisitions totaled 166,722 CAD in value, involving 100,000 shares. No selling activity occurred during this period, and the company has not released a recent earnings report.